Skip to main content
. 2024 Sep 23;19(1):89. doi: 10.1007/s11657-024-01447-7

Fig. 3.

Fig. 3

Forest plot of meta-analysis result in risk of fractures and percent changes at femoral neck BMD. A Teriparatide vs. bisphosphonates in risk of fractures. B denosumab vs. bisphosphonates in risk of fractures. C Teriparatide vs. bisphosphonates in percent changes at femoral neck BMD. D Denosumab vs. bisphosphonates in percent changes at femoral neck BMD